Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Real Life (T-ACI): A Prospective Single-Center Observational Study

Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Real Life (T-ACI): A Prospective Single-Center Observational Study

<b>Background:</b> Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) poses significant challenges in healthcare due to its multidrug resistance and high mortality rates among critically ill patients. <b>Results:</b> We enrolled 45 patients. Cefiderocol wa...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Antonio Riccardo Buonomo, Riccardo Scotto, Nunzia Esposito, Giulio Viceconte, Nicola Schiano Moriello, Giulia Zumbo, Ilaria Vecchietti, Amedeo Lanzardo, Carmine Iacovazzo, Francesco Curcio, Emanuela Roscetto, Ivan Gentile
Formato:	Artigo
Idioma:	English
Publicado em:	MDPI AG 2024-10-01
coleção:	Antibiotics
Assuntos:	<i>Acinetobacter baumannii</i> CRAB cefiderocol colistin
Acesso em linha:	https://www.mdpi.com/2079-6382/13/11/1007

Registros relacionados

Cefiderocol for Severe Carbapenem-Resistant <i>A. baumannii</i> Pneumonia: Towards the Comprehension of Its Place in Therapy
por: Emanuele Rando, et al.
Publicado em: (2021-12-01)

Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
por: Yangyang Zhan, et al.
Publicado em: (2024-09-01)

EFFICACY OF COLISTIN AND CEFIDEROCOL ON CARBAPENEM RESISTANT Acinetobacter baumannii ISOLATES
por: Feyza Balci, et al.
Publicado em: (2024-12-01)

In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii clinical isolates: a single center experience.
por: Giovanni Matera
Publicado em: (2023-06-01)

Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak
por: Giovanna Travi, et al.
Publicado em: (2024-08-01)

Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic
por: Maria Mazzitelli, et al.
Publicado em: (2023-04-01)

Cefiderocol Efficacy in a Real-Life Setting: Single-Centre Retrospective Study
por: Gabriele Palermo, et al.
Publicado em: (2023-04-01)

Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
por: Siqin Zhang, et al.
Publicado em: (2024-07-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
por: Nalumon Thadtapong, et al.
Publicado em: (2021-08-01)

Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Real Life, Prospective, Observational, Single-Center Study
por: Lidia Dalfino, et al.
Publicado em: (2023-06-01)

Glycine restores the sensitivity to antibiotics in multidrug-resistant bacteria
por: Cesira Giordano, et al.
Publicado em: (2024-08-01)

Cefiderocol in Combating Carbapenem-Resistant <i>Acinetobacter baumannii</i>: Action and Resistance
por: Bahman Yousefi, et al.
Publicado em: (2024-11-01)

Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
por: Montserrat Rodríguez-Aguirregabiria, et al.
Publicado em: (2024-08-01)

Transmission cluster of cefiderocol-non-susceptible carbapenem-resistant Acinetobacter baumannii in cefiderocol-naïve individuals
por: Claudia Alteri, et al.
Publicado em: (2024-11-01)

Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance
por: Lavinia Morosi, et al.
Publicado em: (2024-12-01)

First report of an Enterobacter cloacae ST837 resistant to cefiderocol co-harbouring blaIMP-19 and mcr-4.3 resistance genes in Italy
por: Ilaria Menozzi, et al.
Publicado em: (2025-05-01)

Ventilator-associated pneumonia (VAP) and pleural empyema caused by multidrug-resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report
por: Rosa Anna Passerotto, et al.
Publicado em: (2023-06-01)

High-Loading-Dose Colistin with Nebulized Administration for Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia in Critically Ill Patients: A Retrospective Cohort Study
por: Wasan Katip, et al.
Publicado em: (2024-03-01)

Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic Management
por: Harmanjit Singh, et al.
Publicado em: (2013-11-01)

Human Serum Proteins and Susceptibility of <i>Acinetobacter baumannii</i> to Cefiderocol: Role of Iron Transport
por: Casin Le, et al.
Publicado em: (2022-03-01)

Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in <i>Acinetobacter</i> spp.
por: Katy Jeannot, et al.
Publicado em: (2023-07-01)

Clinical Efficacy and Nephrotoxicity of the Loading Dose Colistin for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients
por: Wasan Katip, et al.
Publicado em: (2021-12-01)

Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study
por: Davide Fiore Bavaro, et al.
Publicado em: (2023-09-01)

Colistin Dependency among Colistin-Heteroresistant <i>Acinetobacter baumannii</i> Isolates
por: Hadas Kon, et al.
Publicado em: (2021-12-01)

Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates
por: Clara Ballesté-Delpierre, et al.
Publicado em: (2022-01-01)

Effectiveness and Nephrotoxicity of Loading Dose Colistin–Meropenem versus Loading Dose Colistin–Imipenem in the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
por: Wasan Katip, et al.
Publicado em: (2022-06-01)

Antimicrobial Treatment Strategies for <i>Steno</i><i>trophomonas maltophilia</i>: A Focus on Novel Therapies
por: Jean Gibb, et al.
Publicado em: (2021-10-01)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples
por: Davide Carcione, et al.
Publicado em: (2021-10-01)

Alteration in the Morphological and Transcriptomic Profiles of <i>Acinetobacter baumannii</i> after Exposure to Colistin
por: Eun-Jeong Yoon, et al.
Publicado em: (2024-08-01)

Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria
por: Russell E. Lewis, et al.
Publicado em: (2024-08-01)

Treatment Strategies of Colistin Resistance <i>Acinetobacter baumannii</i> Infections
por: Andria Papazachariou, et al.
Publicado em: (2024-05-01)

Salvage Therapy with Rezafungin for <i>Candida parapsilosis</i> Spondylodiscitis: A Case Report from Expanded Access Program
por: Giulio Viceconte, et al.
Publicado em: (2024-04-01)

Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
por: Giulio Viceconte, et al.
Publicado em: (2023-08-01)

The Iron Content of Human Serum Albumin Modulates the Susceptibility of <i>Acinetobacter baumannii</i> to Cefiderocol
por: Jenny Escalante, et al.
Publicado em: (2023-02-01)

Absence of <i>mgrB</i> Alleviates Negative Growth Effects of Colistin Resistance in <i>Enterobacter cloacae</i>
por: Jessie E. Wozniak, et al.
Publicado em: (2020-11-01)

Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in <i>Acinetobacter baumannii</i>
por: Natalia Kolesnik-Goldmann, et al.
Publicado em: (2023-07-01)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
por: Jae-Min Park, et al.
Publicado em: (2021-07-01)

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
por: Arta Karruli, et al.
Publicado em: (2023-12-01)

RapidResa Polymyxin <i>Acinetobacter</i> NP<sup>®</sup> Test for Rapid Detection of Polymyxin Resistance in <i>Acinetobacter baumannii</i>
por: Maxime Bouvier, et al.
Publicado em: (2021-05-01)

Antibiotic Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence
por: Francesca Serapide, et al.
Publicado em: (2024-05-01)